Key PointsDurvalumab plus lenalidomide has an acceptable safety profile with durable responses in refractory/advanced CTCL in a phase 1 study.Immune checkp
In this issue of Blood, Wuliji and colleagues evaluate the relationship between social determinants of health and access to hematopoietic transplantation i
In this Letter to the Editor, Khushali Jhaveri, MD, reflects on her experience as an international medical graduate from India working in the U.S. A…
Key PointsUHRAs dissociate PF4 antigenic complexes, which disrupts the expression of the epitope(s) recognized by HIT antibodies.UHRAs disrupt (re)assembly
Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by thrombosis and/or recurrent fetal loss accompanied by persistently positive t
Abstract. Between 2019 and 2021, the American Society of Hematology (ASH) developed clinical guidelines for managing sickle cell disease (SCD), covering ac
Abstract. The MCL35 gene expression assay encompasses key risk features and stratified older patients with mantle cell lymphoma (MCL) using routine biopsie
The U.S. Food and Drug Administration (FDA) approved fitusiran for prophylaxis to prevent or reduce bleeding episode frequency in adult and pediatric patients 12 years…
A previously healthy 7-year-old African American boy was admitted for anemia and hemoglobinuria. He appeared well, with reassuring vitals and physical examination. Complete blood count…
Abstract. The disease shift of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL), so-called Richter transformation (RT), is a cat
AbstractBackgroundIn patients with bone marrow transplantation (BMT) for hematologic malignancies, evidence for prevention of cancer therapy-related cardiac dysfunction (CTRCD) remains limited.Obje…
